CME is preparing to list options for Ethereum futures

This is an important signal for Ethereum and a marker of its financial significance, given that the CME management confirmed that this decision was made following significant volumes recorded by ETH futures.

We’re talking about the world’s most important derivatives market, whether it’s futures or options. The market which already quotes futures and simple options on Ethereum, and which, on the permission of the regulator, will also offer options on buying and selling Ethereum futures.

This is an important step forward for Ethereum, as well as for CME, which in the US remains the preferred market for those who want to receive financial support for Bitcoin and specifically Ethereum. This is a step forward, which in the coming years is likely to spread to other cryptocurrencies with high capitalization.

The listing will also appear a few days before the “Merger”, assuming that it also happens on the set dates. It is going to be a hot September for ETH and all the associated products, both financially and operationally.

The largest absentee in the US is still the ETF

In such a financially developed market as the American one, one important element is still missing, namely a spot ETF, that is, an ETF that directly holds Bitcoin, and later, possibly, Ethereum. This situation should be blamed on the resistance of the SEC and its director Gary Gensler, who continues to give preference to securities that copy futures.

A situation that can only be unblocked by changes in the top management of SEC and, perhaps, given that this is the issue being discussed at the highest level, in the White House. For now, Ethereum enthusiasts will have to settle for this important new contract.

But, what is happening today with the price of ETH?

Yes, it’s a little more complicated here than with the Chicago Mercantile Exchange, as since last Friday the crypto asset, and the entire market has fallen. It has lost 18 percent of its value.

Now Ethereum has begun its recovery, balancing at around $1,600 and $1,700.

It`s hard to say that everything looks optimistic, since we clearly see the asset inability to hold on to the support level, not to mention breaking through resistance above $2,000. But, the recovery continues, and all of the good news, including the listing on the CME and the approach of the “Merger” will definitely contribute to the price growth.